Free Trial

Tilray Brands (TLRY) Competitors

Tilray Brands logo
$0.41 +0.01 (+3.42%)
As of 06/30/2025 04:00 PM Eastern

TLRY vs. AHCO, NEOG, BLFS, PAHC, KMTS, INMD, CBLL, EOLS, OMI, and MRVI

Should you be buying Tilray Brands stock or one of its competitors? The main competitors of Tilray Brands include AdaptHealth (AHCO), Neogen (NEOG), BioLife Solutions (BLFS), Phibro Animal Health (PAHC), Kestra Medical Technologies (KMTS), InMode (INMD), CeriBell (CBLL), Evolus (EOLS), Owens & Minor (OMI), and Maravai LifeSciences (MRVI). These companies are all part of the "med products" industry.

Tilray Brands vs. Its Competitors

Tilray Brands (NASDAQ:TLRY) and AdaptHealth (NASDAQ:AHCO) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, earnings, valuation, institutional ownership, media sentiment and risk.

AdaptHealth has a net margin of 2.63% compared to Tilray Brands' net margin of -113.85%. AdaptHealth's return on equity of 6.96% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Tilray Brands-113.85% -7.40% -6.02%
AdaptHealth 2.63%6.96%2.40%

Tilray Brands has a beta of 1.83, indicating that its stock price is 83% more volatile than the S&P 500. Comparatively, AdaptHealth has a beta of 1.64, indicating that its stock price is 64% more volatile than the S&P 500.

AdaptHealth has higher revenue and earnings than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than AdaptHealth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tilray Brands$788.94M0.53-$244.98M-$1.05-0.39
AdaptHealth$3.26B0.39$90.42M$0.5716.54

Tilray Brands currently has a consensus price target of $1.92, indicating a potential upside of 362.52%. AdaptHealth has a consensus price target of $13.40, indicating a potential upside of 42.10%. Given Tilray Brands' higher probable upside, research analysts clearly believe Tilray Brands is more favorable than AdaptHealth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tilray Brands
0 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.25
AdaptHealth
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00

9.4% of Tilray Brands shares are owned by institutional investors. Comparatively, 82.7% of AdaptHealth shares are owned by institutional investors. 0.6% of Tilray Brands shares are owned by company insiders. Comparatively, 1.6% of AdaptHealth shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Tilray Brands had 9 more articles in the media than AdaptHealth. MarketBeat recorded 13 mentions for Tilray Brands and 4 mentions for AdaptHealth. AdaptHealth's average media sentiment score of 0.63 beat Tilray Brands' score of 0.38 indicating that AdaptHealth is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tilray Brands
1 Very Positive mention(s)
0 Positive mention(s)
11 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
AdaptHealth
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

AdaptHealth beats Tilray Brands on 12 of the 16 factors compared between the two stocks.

Get Tilray Brands News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TLRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLRY vs. The Competition

MetricTilray BrandsMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$403.30M$10.44B$5.45B$8.90B
Dividend YieldN/A2.10%5.36%4.13%
P/E Ratio-0.3917.2826.3919.66
Price / Sales0.5328.57406.37110.24
Price / CashN/A23.5625.8827.49
Price / Book0.103.657.925.42
Net Income-$244.98M$233.36M$3.15B$248.34M
7 Day Performance8.54%1.43%0.66%0.82%
1 Month Performance-5.43%3.03%4.95%5.01%
1 Year Performance-75.33%-11.77%32.31%18.10%

Tilray Brands Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLRY
Tilray Brands
1.8662 of 5 stars
$0.41
+3.4%
$1.92
+362.5%
-75.0%$403.30M$788.94M-0.392,650
AHCO
AdaptHealth
3.7422 of 5 stars
$8.51
+2.5%
$13.40
+57.6%
-5.7%$1.15B$3.26B14.9610,500Positive News
NEOG
Neogen
3.8077 of 5 stars
$4.83
+1.2%
$9.00
+86.5%
-69.4%$1.05B$906.00M-2.162,110Analyst Forecast
BLFS
BioLife Solutions
3.0373 of 5 stars
$22.04
+3.2%
$31.17
+41.4%
+0.5%$1.05B$82.25M-75.96440Positive News
PAHC
Phibro Animal Health
3.6323 of 5 stars
$24.60
+0.6%
$20.80
-15.4%
+52.3%$996.84M$1.02B31.531,940
KMTS
Kestra Medical Technologies
N/A$17.17
+7.3%
$27.50
+60.2%
N/A$881.68MN/A0.00300
INMD
InMode
3.6734 of 5 stars
$13.82
+2.4%
$18.54
+34.2%
-20.8%$872.93M$394.82M5.93480
CBLL
CeriBell
2.7322 of 5 stars
$19.35
+4.7%
$32.14
+66.1%
N/A$711.78M$65.44M0.00N/AGap Up
EOLS
Evolus
4.0342 of 5 stars
$9.51
+1.4%
$23.75
+149.7%
-15.1%$613.72M$266.27M-10.69170
OMI
Owens & Minor
4.3475 of 5 stars
$7.43
+2.0%
$12.33
+66.0%
-32.6%$573.58M$10.70B-1.5623,200
MRVI
Maravai LifeSciences
3.5622 of 5 stars
$2.10
-0.7%
$6.64
+216.9%
-66.3%$533.51M$241.86M-1.84610

Related Companies and Tools


This page (NASDAQ:TLRY) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners